Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Phathom Pharmaceuticals (PHAT) Cost of Revenue: 2023-2024

Historic Cost of Revenue for Phathom Pharmaceuticals (PHAT) over the last 2 years, with Dec 2024 value amounting to $8.0 million.

  • Phathom Pharmaceuticals' Cost of Revenue rose 162.73% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.8 million, marking a year-over-year increase of 333.92%. This contributed to the annual value of $8.0 million for FY2024, which is 4674.25% up from last year.
  • Phathom Pharmaceuticals' Cost of Revenue amounted to $8.0 million in FY2024, which was up 4,674.25% from $167,000 recorded in FY2023.
  • Phathom Pharmaceuticals' Cost of Revenue's 5-year high stood at $8.0 million during FY2024, with a 5-year trough of $167,000 in FY2023.
  • For the 2-year period, Phathom Pharmaceuticals' Cost of Revenue averaged around $4.1 million, with its median value being $4.1 million (2023).
  • Data for Phathom Pharmaceuticals' Cost of Revenue shows a peak YoY spiked of 4,674.25% (in 2024) over the last 5 years.
  • Over the past 2 years, Phathom Pharmaceuticals' Cost of Revenue (Yearly) stood at $167,000 in 2023, then surged by 4,674.25% to $8.0 million in 2024.